MPO and Hepatic fibrosis: In line with this notion, genetic knockout or therapeutic inhibition of myeloperoxidase (MPO), one of the primary ROS-producing enzymes in neutrophils, reduces high-fat and high-cholesterol-induced liver fibrosis in mice [34].